PTPI
Petros Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.01
+20.00%Jun 5, 2026, 00:00 UTC
Petros Pharmaceuticals granted restricted shares to Chairman Joshua Silverman, director Bruce Bernstein, President and Chief Commercial Officer Fady Boctor, and director Wayne Walker on June 5, 2026.